Modeling of Frontotemporal Dementia Using iPSC Technology

Modeling of Frontotemporal Dementia Using iPSC Technology

Frontotemporal dementia (FTD) is caused by the progressive degeneration of the frontal and temporal lobes of the brain. Behavioral variant FTD (bvFTD) is the most common clinical subtype of FTD and pathological subtypes of bvFTD are known as FTD-tau, transactive response (TAR) DNA-binding protein 43...

Full description

Bibliographic Details
Main Authors:	Minchul Kim, Hee Jin Kim, Wonyoung Koh, Ling Li, Hyohoon Heo, Hanna Cho, Chul Hyoung Lyoo, Sang Won Seo, Eun-Joo Kim, Mahito Nakanishi, Duk L. Na, Jihwan Song
Format:	Article
Language:	English
Published:	MDPI AG 2020-07-01
Series:	International Journal of Molecular Sciences
Subjects:	frontotemporal dementia (FTD) induced pluripotent stem cells (iPSC) disease modeling cell death staurosporine (STS) drug screening
Online Access:	https://www.mdpi.com/1422-0067/21/15/5319

Similar Items

The EBiSC iPSC bank for disease studies
by: Rachel Steeg, et al.
Published: (2020-12-01)

Human iPSC banking: barriers and opportunities
by: Ching-Ying Huang, et al.
Published: (2019-10-01)

Glutamate-glutamine homeostasis is perturbed in neurons and astrocytes derived from patient iPSC models of frontotemporal dementia
by: Blanca I. Aldana, et al.
Published: (2020-09-01)

Neuroinflammation in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia and the Interest of Induced Pluripotent Stem Cells to Study Immune Cells Interactions With Neurons
by: Elise Liu, et al.
Published: (2021-12-01)

Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B
by: Yu Zhang, et al.
Published: (2017-03-01)

Human iPSC-derived glia models for the study of neuroinflammation
by: Nina Stöberl, et al.
Published: (2023-10-01)

Suspension culture improves iPSC expansion and pluripotency phenotype
by: Nerea Cuesta-Gomez, et al.
Published: (2023-06-01)

Skeletal dysplasia-causing TRPV4 mutations suppress the hypertrophic differentiation of human iPSC-derived chondrocytes
by: Amanda R Dicks, et al.
Published: (2023-02-01)

Generation of two iPSC lines from patient with Mucopolysaccharidosis IV B type and autosomal recessive non-syndromic hearing loss 12
by: I.O. Panchuk, et al.
Published: (2023-09-01)

iPSC-Derived Natural Killer Cell Therapies - Expansion and Targeting
by: Benjamin H. Goldenson, et al.
Published: (2022-02-01)

iPSC-Derived Cardiomyocytes in Inherited Cardiac Arrhythmias: Pathomechanistic Discovery and Drug Development
by: Eline Simons, et al.
Published: (2023-01-01)

iPSC-Cardiomyocyte Models of Brugada Syndrome—Achievements, Challenges and Future Perspectives
by: Aleksandra Nijak, et al.
Published: (2021-03-01)

Blood–Brain Barrier and Neurodegenerative Diseases—Modeling with iPSC-Derived Brain Cells
by: Ying-Chieh Wu, et al.
Published: (2021-07-01)

Immune cells and RBCs derived from human induced pluripotent stem cells: method, progress, prospective challenges
by: Jin-he Jiang, et al.
Published: (2024-01-01)

Choline Ameliorates Disease Phenotypes in Human iPSC Models of Rett Syndrome
by: Chin, Eunice W. M., et al.
Published: (2016)

Psychiatric Misdiagnosis in Frontotemporal Dementia
by: A. Yay Pençe, et al.
Published: (2022-06-01)

Phenocopy syndrome of frontotemporal dementia
by: D. Martins, et al.
Published: (2021-04-01)

Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies
by: Suman C. Nath, et al.
Published: (2023-11-01)

Particulate matter from car exhaust alters function of human iPSC-derived microglia
by: Henna Jäntti, et al.
Published: (2024-02-01)

Comparison of two protocols for the generation of iPSC-derived human astrocytes
by: Patrycja Mulica, et al.
Published: (2023-09-01)

Characterization of cardiac metabolism in iPSC-derived cardiomyocytes: lessons from maturation and disease modeling
by: Sofija Vučković, et al.
Published: (2022-07-01)

The clinical spectrum of frontotemporal dementia
by: Mandić-Stojmenović Gorana, et al.
Published: (2018-01-01)

C5a Activates a Pro-Inflammatory Gene Expression Profile in Human Gaucher iPSC-Derived Macrophages
by: Jacquelyn C. Serfecz, et al.
Published: (2021-09-01)

Dysregulated Cell Homeostasis and miRNAs in Human iPSC-Derived Cardiomyocytes from a Propionic Acidemia Patient with Cardiomyopathy
by: Mar Álvarez, et al.
Published: (2023-01-01)

iPSC-Derived MSCs Are a Distinct Entity of MSCs with Higher Therapeutic Potential than Their Donor-Matched Parental MSCs
by: Hae-Ri Lee, et al.
Published: (2023-01-01)

Generation of an Alagille syndrome (ALGS) patient-derived induced pluripotent stem cell line (TRNDi032-A) carrying a heterozygous mutation (p.Cys682Leufs*7) in the JAG1 gene
by: Omer Hatim, et al.
Published: (2023-12-01)

Generation and Evaluation of Isogenic iPSC as a Source of Cell Replacement Therapies in Patients with Kearns Sayre Syndrome
by: Glen Lester Sequiera, et al.
Published: (2021-03-01)

The Biological Evaluation of Jellyfish Collagen as a New Research Tool for the Growth and Culture of iPSC Derived Microglia
by: Andrew Mearns-Spragg, et al.
Published: (2020-08-01)

Recent advances in human iPSC-derived models of the blood–brain barrier
by: Michael J. Workman, et al.
Published: (2020-04-01)

A PIANO (Proper, Insufficient, Aberrant, and NO Reprogramming) Response to the Yamanaka Factors in the Initial Stages of Human iPSC Reprogramming
by: Kejin Hu
Published: (2020-05-01)

Targeted Integration of Inducible Caspase-9 in Human iPSCs Allows Efficient <i>in vitro</i> Clearance of iPSCs and iPSC-Macrophages
by: Alexandra Lipus, et al.
Published: (2020-04-01)

Progress and emerging techniques for biomaterial-based derivation of mesenchymal stem cells (MSCs) from pluripotent stem cells (PSCs)
by: Nityanand Prakash, et al.
Published: (2023-04-01)

GRN−/− iPSC-derived cortical neurons recapitulate the pathological findings of both frontotemporal lobar degeneration and neuronal ceroidolipofuscinosis
by: Patrizia Bossolasco, et al.
Published: (2022-12-01)

Robust and Scalable Angiogenesis Assay of Perfused 3D Human iPSC-Derived Endothelium for Anti-Angiogenic Drug Screening
by: Vincent van Duinen, et al.
Published: (2020-07-01)

The use of iPSC technology for modeling Autism Spectrum Disorders
by: Fabiele Baldino Russo, et al.
Published: (2019-10-01)

The brain basis of musicophilia: evidence from frontotemporal lobar degeneration
by: Phillip David Fletcher, et al.
Published: (2013-06-01)

Induced pluripotent stem cell (iPSC) line MLi005-A derived from a patient with dominant dystrophic epidermolysis bullosa (DDEB)
by: Sandra Ropret, et al.
Published: (2024-03-01)

Induced pluripotent stem cell (iPSC) line MLi-004A derived from a patient with recessive dystrophic epidermolysis bullosa (RDEB)
by: Sandra Ropret, et al.
Published: (2021-08-01)

TREM2 Alzheimer’s variant R47H causes similar transcriptional dysregulation to knockout, yet only subtle functional phenotypes in human iPSC-derived macrophages
by: Hazel Hall-Roberts, et al.
Published: (2020-11-01)

A cell therapy approach based on iPSC-derived midbrain organoids for the restoration of motor function in a Parkinson’s disease mouse model
by: Chong-Lei Fu, et al.
Published: (2024-01-01)